In dipyridamole-treated glioma cells, the levels of PERK/eIF2α phosphorylation paralleled with YAP1 phosphorylation and YAP1 reduction, while the pharmacological and genetic inhibition of ER stress alleviated dipyridamole-induced changes in YAP1. The gene discussed is EIF2A; the disease is central nervous system cancer.